PHG
Koninklijke Philips NV ADR
NYSE: PHG · HEALTHCARE · MEDICAL DEVICES
$25.58
-5.68% today
Updated 2026-04-29
Market cap
$24.33B
P/E ratio
23.47
P/S ratio
1.37x
EPS (TTM)
$1.09
Dividend yield
3.96%
52W range
$22 – $33
Volume
1.0M
Koninklijke Philips NV ADR (PHG) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $26.98B | $26.84B | $26.39B | $23.19B | $25.42B | $22.58B | $24.79B | $23.33B | $21.39B | $24.24B | $24.52B | $17.78B | $18.12B | $17.15B | $17.31B | $17.16B | $17.83B | $18.17B | $18.02B | $17.83B |
| Revenue growth (YoY) | — | -0.5% | -1.7% | -12.1% | +9.6% | -11.2% | +9.8% | -5.9% | -8.3% | +13.3% | +1.1% | -27.5% | +1.9% | -5.4% | +1.0% | -0.9% | +3.9% | +1.9% | -0.8% | -1.0% |
| Cost of revenue | $18.68B | $17.65B | $17.92B | $15.11B | $15.87B | $13.93B | $15.38B | $13.64B | $13.19B | $14.39B | $13.90B | $9.60B | $9.57B | $9.20B | $9.40B | $9.99B | $10.63B | $10.72B | $10.25B | $9.78B |
| Gross profit | $8.30B | $9.18B | $8.47B | $8.08B | $9.55B | $8.65B | $9.41B | $9.69B | $8.21B | $9.86B | $10.61B | $8.18B | $8.55B | $7.95B | $7.91B | $7.17B | $7.19B | $7.45B | $7.77B | $8.06B |
| Gross margin | 30.8% | 34.2% | 32.1% | 34.8% | 37.6% | 38.3% | 38.0% | 41.5% | 38.4% | 40.7% | 43.3% | 46.0% | 47.2% | 46.4% | 45.7% | 41.8% | 40.4% | 41.0% | 43.1% | 45.2% |
| R&D | $1.67B | $1.63B | $1.78B | $1.63B | $1.58B | $1.61B | $1.81B | $1.73B | $1.64B | $1.93B | $2.02B | $1.76B | $1.76B | $1.79B | $1.91B | $1.81B | $2.09B | $1.89B | $1.75B | $1.70B |
| SG&A | $3.66B | $4.13B | $1.01B | $734.00M | $735.00M | $841.00M | $798.00M | $949.00M | $747.00M | $1.21B | $845.00M | $577.00M | $631.00M | $586.00M | $630.00M | $599.00M | $671.00M | $608.00M | $582.00M | $628.00M |
| Operating income | $1.18B | $1.85B | $54.00M | $614.00M | $2.06B | $-269.00M | $1.03B | $1.99B | $486.00M | $992.00M | $1.88B | $1.52B | $1.72B | $1.37B | $1.26B | $553.00M | $-1.53B | $-115.00M | $529.00M | $1.42B |
| Operating margin | 4.4% | 6.9% | 0.2% | 2.6% | 8.1% | -1.2% | 4.2% | 8.5% | 2.3% | 4.1% | 7.7% | 8.5% | 9.5% | 8.0% | 7.3% | 3.2% | -8.6% | -0.6% | 2.9% | 8.0% |
| EBITDA | $2.01B | $2.71B | $656.00M | $2.31B | $3.63B | $1.03B | $1.94B | $3.10B | $1.79B | $1.75B | $2.35B | $2.65B | $2.79B | $2.62B | $2.75B | $2.00B | $115.00M | $1.04B | $1.85B | $2.64B |
| EBITDA margin | 7.5% | 10.1% | 2.5% | 10.0% | 14.3% | 4.6% | 7.8% | 13.3% | 8.4% | 7.2% | 9.6% | 14.9% | 15.4% | 15.3% | 15.9% | 11.6% | 0.6% | 5.7% | 10.3% | 14.8% |
| EBIT | $1.18B | $1.86B | $-534.00M | $839.00M | $2.21B | $-422.00M | $507.00M | $1.75B | $600.00M | $473.00M | $1.09B | $1.62B | $1.71B | $1.72B | $1.69B | $673.00M | $-1.49B | $-220.00M | $460.00M | $1.51B |
| Interest expense | $4.79B | $5.75B | $246.00M | $391.00M | $336.00M | $352.00M | $352.00M | $400.00M | $415.00M | $467.00M | $569.00M | $263.00M | $264.00M | $209.30M | $193.80M | $164.00M | $244.00M | $306.00M | $337.00M | $332.34M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $5.38B | $4.17B | $-92.00M | $410.00M | $1.45B | $-1.29B | $226.00M | $1.17B | $415.00M | $645.00M | $1.45B | $1.66B | $1.09B | $1.17B | $1.19B | $3.32B | $-1.61B | $-466.00M | $-702.00M | $895.00M |
| Net income growth (YoY) | — | -22.4% | -102.2% | +545.7% | +252.7% | -189.6% | +117.5% | +417.3% | -64.5% | +55.4% | +124.5% | +14.4% | -34.2% | +7.1% | +1.7% | +179.6% | -148.4% | +71.0% | -50.6% | +227.5% |
| Profit margin | 20.0% | 15.6% | -0.3% | 1.8% | 5.7% | -5.7% | 0.9% | 5.0% | 1.9% | 2.7% | 5.9% | 9.3% | 6.0% | 6.8% | 6.9% | 19.3% | -9.0% | -2.6% | -3.9% | 5.0% |